Back to today’s briefing

Story perspectives

Taiwanese Researchers Unveil Breakthrough CAR-T Therapy for Solid Tumors

2/24/2026

50 11 Full Breakdown

Summary

Story summary

Researchers in Taiwan have developed CAR001, a novel therapy for solid tumors using ?? T-cells.
Early clinical observations show a 70% reduction in circulating tumor cells and functional improvements.
Solid tumors comprise over 90% of cases, a domain where CAR-T therapies have struggled.
Future developments include in vivo EXO 001 CAR-T, which aims to simplify treatment and expand access.

1 of 1

Story summary

Researchers in Taiwan have developed CAR001, a novel therapy for solid tumors using ?? T-cells.
Early clinical observations show a 70% reduction in circulating tumor cells and functional improvements.
Solid tumors comprise over 90% of cases, a domain where CAR-T therapies have struggled.
Future developments include in vivo EXO 001 CAR-T, which aims to simplify treatment and expand access.